Cor Vasa 2012, 54(11-12):e369-e374 | DOI: 10.1016/j.crvasa.2012.11.007
Catheter ablation for atrial fibrillation - Single center experience
- I. interní kardioangiologická klinika, Lékařská fakulta Univerzity Karlovy v Hradci Králové a Fakultní nemocnice Hradec Králové, Hradec Králové, Česká republika
Aims: Catheter ablation (CA) has become standard therapy for atrial fibrillation, especially for paroxysmal atrial fibrillation. Precise single center follow-up (FU) data (especially long-term FU data) are published infrequently.
Methods: We studied 303 consecutive patients (172 males, 131 females, mean age 57 years) who underwent catheter ablation for atrial fibrillation (489 procedures) in years 2004-2012. Clinical examination, ECG, 24-h or 7-day Holter monitoring and quality-of-life (QoL) measurement (EQ-5D) was performed at 3-, 6-, 12-, 18- and 24-month FU.
Results: FU data longer than 6 months after the first procedure are available for 135 patients with paro-xysmal, 84 patients with persistent and 48 patients with long-standing persistent AF. The success rate after 6 months after the first procedure (sinus rhythm without AA drugs, no arrhythmias) was 48% for paroxysmal, 43% for persistent and 44% for long-standing persistent AF. The complication rate was 3.3% (16 patients, no deaths, no pulmonary vein stenosis, 5 incidents of pericardial effusion treated with pericardiocentesis; 1 transitory ischemic attack; the remainder were local complications in the groin). The success rate after the last procedure (mean FU 24 ± 16 months, 1.6 procedure per patient) was 80% for paroxysmal and 58% for persistent and long-standing persistent AF. QoL increased significantly in all groups of patients.
Conclusion: With the standard procedure we can achieve acceptable results (success rate 60-80% with repeated procedures) with low complication rate even in a "lower volume" center. In selected patients (with paroxysmal AF preferring interventional treatment) CA can be recommended as first-line therapy for rhythm control. CA improves QoL in our patients with AF. As there is no gold standard to measure QoL in AF pa-tients, EQ-5D seems to be a simple, quick and useful tool.
Keywords: Atrial fibrillation; Catheter ablation; Quality of life
Received: October 17, 2012; Revised: November 10, 2012; Accepted: November 12, 2012; Published: November 1, 2012 Show citation
References
- C. Pappone, V. Santinelli, Atrial fibrillation: state of the art, The American Journal of Cardiology 96 (2005) 59L-64L.
Go to original source...
Go to PubMed...
- M.D. O'Neill, M. Wright, S. Knecht, et al., Long-term follow-up of persistent atrial fibrillation ablation using termination as a procedural endpoint, European Heart Journal 30 (2009) 1105-1112.
Go to original source...
Go to PubMed...
- M. Fiala, J. Chovancík, D. Wojnarová, et al., Results of complex left atrial ablation of long-lasting persistent atrial fibrillation, Journal of Interventional Cardiac Electrophysiology 23 (2008) 189-198.
Go to original source...
Go to PubMed...
- W. Greiner, T. Weijnen, M. Nieuwenhuizen, et al., A single European currency for EQ-5D health states. Results from a six country study, The European Journal of Health Economics 4 (2003) 222-231.
Go to original source...
Go to PubMed...
- H. Mlcochova, J. Tintera, V. Porod, et al., Magnetic resonance angiography of pulmonary veins: implications for catheter ablation of atrial fibrillation, Pacing and Clinical Electrophysiology 28 (2005) 1073-1080.
Go to original source...
Go to PubMed...
- C. Bonanno, M. Paccanaro, L. La Vecchia, et al., Efficacy and safety of catheter ablation versus antiarrhythmic drugs for atrial fibrillation: a meta-analysis of randomized trials, The Journal of Cardiovascular Medicine 11 (2010) 408-418.
Go to original source...
Go to PubMed...
- R. Cappato, H. Calkins, S.A. Chen, et al., Updated worldwide survey on the methods, efficacy, and safety of catheter ablation for human atrial fibrillation, Circulation. Arrhythmia and Electrophysiology 3 (2010) 32-38.
Go to original source...
Go to PubMed...
- O.M. Wazni, N.F. Marrouche, D.O. Martin, et al., Radiofrequency ablation vs antiarrhythmic drugs as first-line treatment of symptomatic atrial fibrillation. A randomized trial, The Journal of the American Medical Association 293 (2005) 2634-2640.
Go to original source...
Go to PubMed...
- P. Jais, B. Cauchemez, L. Macle, et al., Catheter ablation versus antiarrhythmic drugs for atrial fibrillation: the A4 study, Circulation 118 (2008) 2498-2505.
Go to original source...
Go to PubMed...
- D.J. Wilber, C. Pappone, P. Neuzil, et al., Comparison of antiarrhythmic drug therapy and radiofrequency catheter ablation in patients with paroxysmal atrial fibrillation: A randomized controlled trial, The Journal of the American Medical Association 303 (2010) 333-340.
Go to original source...
Go to PubMed...
- C. Quercioli, G. Mesina, E. Barbini, et al., Importance of sociodemographic and morbidity aspects in measuring health-related quality of life: performance of three tools, The European Journal of Health Economics 10 (2009) 389-397.
Go to original source...
Go to PubMed...
- A.J. Camm, G.Y.H. Lip, R. De Caterina, et al., 2012 focused update of the ESC Guidelines for the management of atrial fibrillation, European Heart Journal 33 (2012) 2719-2747.
Go to original source...
Go to PubMed...